Total Funding
32
53
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
103540
Seeing Medicines is a biotech company focused on regenerative ocular treatments.
- Alan Marmorstein: Co-Founder & Chief Scientific Advisor
LeRoux Jooste: CEO, Co-Founder & PresidentPast Role: Ocata Therapeutics, SVP of Business Development and Chief Commercial Officer
About the Company
Seeing Medicines is a biotech company focused on regenerative ocular treatments. The company's goal is to develop regenerative medicine treatments to restore and maintain vision in people with macular degenerative diseases such as Age-related Macular Degeneration (AMD), Best Disease, and Stargardt Disease.
Seeing Medicines was founded in 2020
and is based in Arden, NC.
